FAST MONEY FEATURES
FAST MONEY POLLGet in the post game. Respond to our "Question of the Day" right now.
FULL SHOWSMissed an episode of Fast Money? Watch the lastest show here.
TRADE SCHOOLGrab a pencil because school is in session and the Fast Money traders are teaching class.
FAST MONEY PODCASTSDownload Fast Money onto your MP3 Player.
FAST MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
SHOP FOR FAST MONEY MERCHANDISEGet your game on with Fast Money gear.
FAST MONEY PHOTOS!Check out our scrapbook. These "pix" are guaranteed winners.
NEWSLETTERSign up and receive a recap email every Friday after the show!
FAST MONEY MOBILE ALERTSGet advanced information about the next Fast Money.
Text Size 
 |
Think there are no investment opportunities in stem cell research? Think again!
Did you know that even without any FDA approvals this year, stem cell product shipments in 2008 are on track to rise to $87 million? In fact the field is growing so quickly that on Tuesday many of the firms currently racing to the forefront of this science met in New York City at the 4th annual Stem Cell Summit.
Considering it's widely believed that President Obama will soon issue an executive order lifting the ban on federal funding for embryonic stem-cell research -- what's the trade?
Geron [GERN
Loading...
()
] is the name many traders talk about as a leader in stem cell research, says Pete Najarian. However, it’s important to keep in mind that major breakthroughs are probably a way out, still.
In the larger space I like Celgene [CELG
Loading...
()
], Genzyme [GENZ
Loading...
()
] and Teva [TEVA
Loading...
()
] for their pipelines. Or if you don’t want to play stock picker, you can get broad exposure with the SPDR S&P Biotech ETF[XBI
Loading...
()
].
Or you can play the iShares NASDAQ Biotechnology Index ETF [IBB
Loading...
()
], adds Karen Finerman.
Personally, my favorite stock in the space is Celgene, adds Guy Adami.
- Your First Move For Tuesday November 24th
- Pops & Drops: Cigna, Verizon...
- Giving Thanks: Energy
- Web Extra: Winning The Chocolate Wars
- Holiday Travel Outlook
- Trading The Dollar Drama
- Prepare For Large Decline In Stocks, Next Year?
- Unusual Options Action w/ Pete Najarian
- Take Your Position: Black Friday
- Mutual Fund Mondays
______________________________________________________
Got something to to say? Send us an e-mail at and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment but not have it published on our website send your e-mail to .
Trader disclosure: On Feb. 17th, 2008, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Seymour Owns (AAPL), (AA), (BAC), (EEM), (XOM), (FXI), (YUM); Seymour's Firm Owns (VIP); Adami Owns (AGU), (BTU), (C), (GS), (INTC), (MSFT), (NUE); Najarian Owns (CELG), (ENER); Najarian Owns (GS) Calls; Najarian Owns (EEM) Call Spread; Najarian Owns (FCX) & (FCX) Calls; Najarian Owns (CHK) Put Spread; Najarian Owns (GDX) Call Spread; Najarian Owns (GLD) Call Spread; Najarian Owns (MSFT) & (MSFT) Short Calls; Najarian Owns (MS) & (MS) Short Calls; Najarian Owns (MOS) Call Spread; Najarian Owns (STI) Call Spread; Finerman's Firm Owns (AET), (CRXL), (MSFT), (XBI), (FL); Finerman's Firm Owns (DNA) & (DNA) Call Spread; Finerman's Firm Is Short (USO), (VNO), (BBT), (IYR), (IJR), (IWM), (MDY), (SPY)
Data is a real-time snapshot *Data is delayed at least 15 minutes